• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018
  • Share to Weibo added to Biovista Vizit October 25, 2017

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

EXENATIDE

Diabetes drugs for Alzheimer’s disease

September 5, 2018Metabolic Disorders, Nervous System Disorders, Vizit Graphs
Diabetes drugs for Alzheimer’s disease

Repurposing Diabetes drugs for Alzheimer’s disease. View pathways associated with the action of Exenatide in Alzheimer’s.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

AGING FOXP3 IL17A CANDIDA ALBICANS PARKINSON DISEASE STAPHYLOCOCCUS AUREUS METFORMIN CLOSTRIDIUM DIFFICILE ANGIOGENESIS NEURODEGENERATIVE DISORDERS CASP3 PORPHYROMONAS GINGIVALIS DOXORUBICIN 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE TH17 CELLS BREAST CANCER IL23A APOPTOTIC PROCESS RECEPTOR SOD1 CANCER LISTERIA MONOCYTOGENES ESCHERICHIA COLI IL6 HELICOBACTER PYLORI CTLA4 AUTOPHAGY STREPTOCOCCUS PNEUMONIAE CELL DIFFERENTIATION DIABETES MELLITUS RHEUMATOID ARTHRITIS INSULIN ERBB-2 TNF IFNG INFLAMMATION CELL DEATH CD4 ALZHEIMER'S DISEASE PSEUDOMONAS AERUGINOSA IMMUNE RESPONSE CELL DIVISION TP53 CELL PROLIFERATION REMICADE

© 2019 Biovista Vizit All Rights Reserved.